0      0


Current Status on CM for Biologics: Development to Clinical


Jun 24, 2020 12:00am ‐ Sep 11, 2020 6:08am


Credits: None available.

Description

Current Status on CM for Biologics: Development to Clinical

Speakers will provide insights on the current stage of deployment of CM for biological molecule clinical manufacturing from the point of view of process technologies, facility assets, and manufacturing operations. Examples of successes as well as challenges encountered will be shared.

  • The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering AstraZeneca
  • Perspectives on the Development of Continuous Manufacturing for Biological Products
    Mark Brower, Principal Scientist
    Merck
  • Novel Technologies to Enable Continuous Manufacturing of Biologics
    Govind Rao, PhD, Director, Center for Advanced Sensor Technology
    University of Maryland, Baltimore County

Moderator(s):

  • Antonio R. Moreira, PhD, Vice Provost, Academic Affairs, University of Maryland, Baltimore County

Speaker(s):

  • Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca
  • Mark Brower, Principal Scientist, Merck & Co., Inc.
  • Govind Rao, PhD, Professor & Director, Center for Advanced Sensor Technology, University of Maryland, Baltimore County

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Ushma Mehta
7/31/20 1:14 pm

Hello, Is Jon Coffman going to share his presentation on "The Biopharmaceutical Industry Emerging Continuous and Integrated Platform for Recombinant Protein" ? Thank you